LifeStance Health Group (LFST) Reports Q4 Loss, Tops Revenue Estimates

Group 1 - LifeStance Health Group reported a quarterly loss of $0.02 per share, better than the Zacks Consensus Estimate of a loss of $0.04, and improved from a loss of $0.12 per share a year ago, representing a 50% earnings surprise [1] - The company achieved revenues of $325.48 million for the quarter ended December 2024, exceeding the Zacks Consensus Estimate by 4.03%, and up from $280.6 million year-over-year [2] - LifeStance Health has surpassed consensus EPS estimates for four consecutive quarters, indicating a strong performance trend [2] Group 2 - The stock has gained approximately 1.9% since the beginning of the year, outperforming the S&P 500's gain of 1.3% [3] - The company's earnings outlook is favorable, with current consensus EPS estimates of -$0.06 on revenues of $339.54 million for the upcoming quarter and -$0.14 on revenues of $1.38 billion for the current fiscal year [7] - The Medical - Outpatient and Home Healthcare industry, to which LifeStance Health belongs, is currently ranked in the top 31% of over 250 Zacks industries, suggesting a positive industry outlook [8]